ATG16L1 and colorectal carcinoma: To more thoroughly address the contribution of necroptosis and apoptosis to organoid cell death, Ripk3 was genetically deleted using CRISPR-Cas9 (Supplementary Fig. 11b) and caspases were pharmacologically inhibited with z-VAD in Atg16l1 KO CRC organoids.